Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Daily News

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

Caitlin E. Cox

December 18, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

Caitlin E. Cox

May 08, 2024

News Conference News ACC 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

L.A. McKeown

April 04, 2024

News Daily News

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

L.A. McKeown

February 21, 2024

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Conference News EAS 2021

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Michael O'Riordan

June 04, 2021

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

L.A. McKeown

August 30, 2019

News Features

Top News in Policy & Practice: 2018

Todd Neale

December 28, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

News Conference News ESC 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Michael O'Riordan

August 29, 2017

Advertisement

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Atherosclerosis Progression May Share Traits With Tumor Growth

Faster CAC Progression After Menopause May Warrant Intensified Therapy

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

Top News in Policy & Practice: 2018

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content